Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 337
Filtrar
1.
Cell Rep Med ; 4(5): 101041, 2023 05 16.
Artigo em Inglês | MEDLINE | ID: mdl-37196630

RESUMO

Shrine et al.1 conducted the largest multi-ancestry genome-wide meta-analysis of lung function and identified 1,020 signals associated with lung function. These provide novel insights into the genetic underpins of lung function and may inform better clinical management of respiratory disorders.


Assuntos
Predisposição Genética para Doença , Doenças Respiratórias , Humanos , Estudo de Associação Genômica Ampla , Doenças Respiratórias/genética , Doenças Respiratórias/terapia , Pulmão
2.
Pharmacogenomics ; 24(5): 239-241, 2023 04.
Artigo em Inglês | MEDLINE | ID: mdl-37014403

RESUMO

Tweetable abstract Opportunities for pharmacogenetics implementation in chronic respiratory diseases through the employment of genotype-guided prescriptions in treating nonrespiratory comorbidities.


Assuntos
Farmacogenética , Doenças Respiratórias , Humanos , Genótipo , Doenças Respiratórias/tratamento farmacológico , Doenças Respiratórias/genética
3.
PLoS One ; 17(11): e0277235, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36395113

RESUMO

Modern society grew rapidly over the last few decades and this led to an alarming increase in air pollutants and a worsening of the human health, especially in relation to the respiratory system. Indeed, chronic respiratory diseases were the third main cause of death in 2017, with over 3 million of deaths. Furthermore, the pollution has considerable consequences both for burden medical expenses and environmental. However, the mechanisms linking pollutants to the onset of these diseases remain unclear. Thus, in this study we addressed this problem through the United Kingdom BioBank database, analyzing 170 genome-wide association studies (103 related to respiratory diseases and 67 related to pollutants). We analyzed the genetic correlations and causal relationships of these traits, leveraging the summary statistics and bioinformatics packages such as Linkage Disequilibrium Score Regression and Latent Causal Variable. We obtained 158 significant genetic correlations and subsequently we analyzed them through the Latent Causal Variable analysis, obtaining 20 significant causal relationships. The most significant were between "Workplace full of chemicals or other fumes: Sometimes" and "Condition that has ever been diagnosed by a doctor: Asthma" and between "Workplace very dusty: Sometimes" and "Condition that has ever been diagnosed by a doctor: Emphysema or chronic bronchitis". Finally, we identified single nucleotide polymorphisms independently associated with sveral pollutants to analyze the genes and pathways that could be involved in the onset of the aforementioned respiratory system disorders and that could be useful clinical target. This study highlighted how crucial are the air condition of the working environments and the type of transport used in the onset of respiratory-related morbidity. Based on that, we also suggested some interventions, in order to improve quality life and develop new and eco-friendly society and life style, such as improving indoor air circulation, the use of public transport and urban reforestation.


Assuntos
Poluentes Atmosféricos , Poluentes Ambientais , Doenças Respiratórias , Humanos , Estudo de Associação Genômica Ampla , Poluentes Atmosféricos/efeitos adversos , Doenças Respiratórias/etiologia , Doenças Respiratórias/genética , Sistema Respiratório
4.
PLoS One ; 17(11): e0277033, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36327246

RESUMO

Bovine respiratory disease (BRD), the leading disease complex in beef cattle production systems, remains highly elusive regarding diagnostics and disease prediction. Previous research has employed cellular and molecular techniques to describe hematological and gene expression variation that coincides with BRD development. Here, we utilized weighted gene co-expression network analysis (WGCNA) to leverage total gene expression patterns from cattle at arrival and generate hematological and clinical trait associations to describe mechanisms that may predict BRD development. Gene expression counts of previously published RNA-Seq data from 23 cattle (2017; n = 11 Healthy, n = 12 BRD) were used to construct gene co-expression modules and correlation patterns with complete blood count (CBC) and clinical datasets. Modules were further evaluated for cross-populational preservation of expression with RNA-Seq data from 24 cattle in an independent population (2019; n = 12 Healthy, n = 12 BRD). Genes within well-preserved modules were subject to functional enrichment analysis for significant Gene Ontology terms and pathways. Genes which possessed high module membership and association with BRD development, regardless of module preservation ("hub genes"), were utilized for protein-protein physical interaction network and clustering analyses. Five well-preserved modules of co-expressed genes were identified. One module ("steelblue"), involved in alpha-beta T-cell complexes and Th2-type immunity, possessed significant correlation with increased erythrocytes, platelets, and BRD development. One module ("purple"), involved in mitochondrial metabolism and rRNA maturation, possessed significant correlation with increased eosinophils, fecal egg count per gram, and weight gain over time. Fifty-two interacting hub genes, stratified into 11 clusters, may possess transient function involved in BRD development not previously described in literature. This study identifies co-expressed genes and coordinated mechanisms associated with BRD, which necessitates further investigation in BRD-prediction research.


Assuntos
Complexo Respiratório Bovino , Doenças dos Bovinos , Transtornos Respiratórios , Doenças Respiratórias , Bovinos , Animais , Doenças Respiratórias/genética , Sistema Respiratório , Redes Reguladoras de Genes , Aumento de Peso/genética , Complexo Respiratório Bovino/genética
5.
Front Immunol ; 13: 1110774, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36685535

RESUMO

Macrophages play an essential role in maintaining the normal function of the innate and adaptive immune responses during host defence. Macrophages acquire diverse functional phenotypes in response to various microenvironmental stimuli, and are mainly classified into classically activated macrophages (M1) and alternatively activated macrophages (M2). Macrophage polarization participates in the inflammatory, fibrotic, and oncogenic processes of diverse respiratory diseases by changing phenotype and function. In recent decades, with the advent of broad-range profiling methods such as microarrays and next-generation sequencing, the discovery of RNA transcripts that do not encode proteins termed "noncoding RNAs (ncRNAs)" has become more easily accessible. As one major member of the regulatory ncRNA family, long noncoding RNAs (lncRNAs, transcripts >200 nucleotides) participate in multiple pathophysiological processes, including cell proliferation, differentiation, and apoptosis, and vary with different stimulants and cell types. Emerging evidence suggests that lncRNAs account for the regulation of macrophage polarization and subsequent effects on respiratory diseases. In this review, we summarize the current published literature from the PubMed database concerning lncRNAs relevant to macrophage polarization and the underlying molecular mechanisms during the occurrence and development of respiratory diseases. These differentially expressed lncRNAs are expected to be biomarkers and targets for the therapeutic regulation of macrophage polarization during disease development.


Assuntos
RNA Longo não Codificante , Transtornos Respiratórios , Doenças Respiratórias , Humanos , RNA Longo não Codificante/genética , RNA Longo não Codificante/metabolismo , Macrófagos , Biomarcadores/metabolismo , Diferenciação Celular/genética , Doenças Respiratórias/genética , Doenças Respiratórias/metabolismo
6.
Arch Dis Child ; 107(2): 141-147, 2022 02.
Artigo em Inglês | MEDLINE | ID: mdl-34134972

RESUMO

OBJECTIVE: This study aimed to investigate the prevalence and clinical characteristics of monogenic disease in paediatric patients with a predominant respiratory phenotype. METHODS: Exome sequencing was performed in a cohort of 971 children with a predominant respiratory phenotype and suspected genetic aetiology. A total of 140 positive cases were divided into subgroups based on recruitment age and the primary biological system(s) involved. RESULTS: There were 140 (14.4%) patients with a positive molecular diagnosis, and their primary clinical manifestations were respiratory distress (12.9%, 18 of 140), respiratory failure (12.9%, 18 of 140) and recurrent/persistent lower respiratory infections (66.4%, 93 of 140). Primary immunodeficiency (49.3%), multisystem malformations/syndromes (17.9%), and genetic lung disease (16.4%) were the three most common genetic causes in the cohort, and they varied among the age subgroups. A total of 72 (51.4%) patients had changes in medical management strategies after genetic diagnosis, and the rate in those with genetic lung disease (82.6%, 19 of 23) was far higher than that in patients with genetic disease with lung involvement (45.3%, 53 of 117) (p=0.001). CONCLUSION: Our findings demonstrate that exome sequencing is a valuable diagnostic tool for monogenic diseases in children with a predominant respiratory phenotype, and the genetic spectrum varies with age. Taken together, genetic diagnoses provide invaluable clinical and prognostic information that may also facilitate the development of precision medicine for paediatric patients.


Assuntos
Doenças Respiratórias/genética , Criança , Pré-Escolar , Doenças Genéticas Inatas/genética , Doenças Genéticas Inatas/patologia , Humanos , Lactente , Recém-Nascido , Pneumopatias/epidemiologia , Pneumopatias/genética , Pneumopatias/patologia , Masculino , Fenótipo , Prevalência , Doenças Respiratórias/epidemiologia , Doenças Respiratórias/patologia , Sequenciamento do Exoma
7.
Int J Mol Sci ; 22(16)2021 Aug 07.
Artigo em Inglês | MEDLINE | ID: mdl-34445208

RESUMO

The transient receptor potential melastatin subtype 8 (TRPM8) is a cold sensor in humans, activated by low temperatures (>10, <28 °C), but also a polymodal ion channel, stimulated by voltage, pressure, cooling compounds (menthol, icilin), and hyperosmolarity. An increased number of experimental results indicate the implication of TRPM8 channels in cold thermal transduction and pain detection, transmission, and maintenance in different tissues and organs. These channels also have a repercussion on different kinds of life-threatening tumors and other pathologies, which include urinary and respiratory tract dysfunctions, dry eye disease, and obesity. This compendium firstly covers newly described papers on the expression of TRPM8 channels and their correlation with pathological states. An overview on the structural knowledge, after cryo-electron microscopy success in solving different TRPM8 structures, as well as some insights obtained from mutagenesis studies, will follow. Most recently described families of TRPM8 modulators are also covered, along with a section of molecules that have reached clinical trials. To finalize, authors provide an outline of the potential prospects in the TRPM8 field.


Assuntos
Temperatura Baixa , Canais de Cátion TRPM , Sensação Térmica , Síndromes do Olho Seco/tratamento farmacológico , Síndromes do Olho Seco/genética , Síndromes do Olho Seco/metabolismo , Humanos , Obesidade/tratamento farmacológico , Obesidade/genética , Obesidade/metabolismo , Doenças Respiratórias/tratamento farmacológico , Doenças Respiratórias/genética , Doenças Respiratórias/metabolismo , Canais de Cátion TRPM/química , Canais de Cátion TRPM/genética , Canais de Cátion TRPM/metabolismo , Doenças Urológicas/tratamento farmacológico , Doenças Urológicas/genética , Doenças Urológicas/metabolismo
8.
Sci Rep ; 11(1): 15823, 2021 08 04.
Artigo em Inglês | MEDLINE | ID: mdl-34349215

RESUMO

Identification of a quantitative trait locus (QTL) related to a chronic respiratory disease such as Mycoplasmal pneumonia of swine (MPS) and immune-related traits is important for the genetic improvement of disease resistance in pigs. The objective of this study was to detect a novel QTL for a total of 22 production, respiratory disease, and immune-related traits in Landrace pigs. A total of 874 Landrace purebred pigs, which were selected based on MPS resistance, were genotyped using the Illumina PorcineSNP60 BeadChip. We performed single nucleotide polymorphism (SNP)-based and haplotype-based genome-wide association studies (GWAS) to detect a novel QTL and to evaluate the possibility of a pleiotropic QTL for these traits. SNP-based GWAS detected a total of six significant regions in backfat thickness, ratio of granular leucocytes to lymphatic cells, plasma concentration of cortisol at different ages, and complement alternative pathway activity in serum. The significant region detected by haplotype-based GWAS was overlapped across the region detected by SNP-based GWAS. Most of these detected QTL regions were novel regions with some candidate genes located in them. With regard to a pleiotropic QTL among traits, only three of these detected QTL regions overlapped among traits, and many detected regions independently affected the traits.


Assuntos
Resistência à Doença/genética , Estudo de Associação Genômica Ampla , Sistema Imunitário/metabolismo , Polimorfismo de Nucleotídeo Único , Locos de Características Quantitativas , Reprodução , Doenças Respiratórias/genética , Animais , Haplótipos , Fenótipo , Doenças Respiratórias/patologia , Suínos
9.
Pediatr Pulmonol ; 56(10): 3157-3165, 2021 10.
Artigo em Inglês | MEDLINE | ID: mdl-34388306

RESUMO

Over the past decade, "omics" approaches have advanced our understanding of the molecular programming of the airways in humans. Several studies have identified potential molecular mechanisms that contribute to early life epigenetic reprogramming, including DNA methylation, histone modifications, microRNAs, and the homeostasis of the respiratory mucosa (epithelial function and microbiota). Current evidence supports the notion that early infancy is characterized by heightened susceptibility to airway genetic reprogramming in response to the first exposures in life, some of which can have life-long consequences. Here, we summarize and analyze the latest insights from studies that support a novel epigenetic paradigm centered on human maturational and developmental programs including three cardinal elements: genes, environment, and developmental timing. The combination of these factors is likely responsible for the functional trajectory of the respiratory system at the molecular, functional, and clinical levels.


Assuntos
Epigênese Genética , MicroRNAs , Doenças Respiratórias/genética , Metilação de DNA , Epigenômica , Humanos , Sistema Respiratório
10.
Commun Biol ; 4(1): 628, 2021 05 26.
Artigo em Inglês | MEDLINE | ID: mdl-34040152

RESUMO

Recent advances in culture-independent microbiological analyses have greatly expanded our understanding of the diversity of unculturable microbes. However, human pathogenic bacteria differing significantly from known taxa have rarely been discovered. Here, we present the complete genome sequence of an uncultured bacterium detected in human respiratory tract named IOLA, which was determined by developing a protocol to selectively amplify extremely AT-rich genomes. The IOLA genome is 303,838 bp in size with a 20.7% GC content, making it the smallest and most AT-rich genome among known human-associated bacterial genomes to our best knowledge and comparable to those of insect endosymbionts. While IOLA belongs to order Rickettsiales (mostly intracellular parasites), the gene content suggests an epicellular parasitic lifestyle. Surveillance of clinical samples provides evidence that IOLA can be predominantly detected in patients with respiratory bacterial infections and can persist for at least 15 months in the respiratory tract, suggesting that IOLA is a human respiratory tract-associated bacterium.


Assuntos
Genoma Bacteriano/genética , Sistema Respiratório/microbiologia , Rickettsiales/genética , Bactérias/genética , Composição de Bases/genética , Genoma Humano/genética , Humanos , Filogenia , Doenças Respiratórias/genética , Doenças Respiratórias/microbiologia , Rickettsiales/patogenicidade , Sequenciamento Completo do Genoma/métodos
11.
Mol Pharm ; 18(6): 2218-2232, 2021 06 07.
Artigo em Inglês | MEDLINE | ID: mdl-34014665

RESUMO

Pulmonary delivery of small interfering RNA (siRNA) is a promising therapeutic strategy for treating various respiratory diseases but an effective carrier for the delivery of siRNA into the cells of the lungs and a robust gene-silencing effect is still lacking. Previously, we reported that the KL4 peptide, a synthetic cationic peptide with a repeating KLLLL sequence, can mediate effective siRNA transfection in lung epithelial cells but its high hydrophobic leucine content, and hence poor water solubility, limits its application as a delivery vector. Here, we show that the covalent attachment of monodisperse poly(ethylene glycol) (PEG) improves the solubility of KL4 and the uptake of its complex with siRNA into lung epithelial cells, such that very robust silencing is produced. All PEGylated KL4 peptides, with PEG length varying between 6 and 24 monomers, could bind and form nanosized complexes with siRNA, but the interaction between siRNA and peptides became weaker as the PEG chain length increased. All PEGylated KL4 peptides exhibited satisfactory siRNA transfection efficiency on three human lung epithelial cell lines, including A549 cells, Calu-3 cells, and BEAS-2B cells. The PEG12KL4 peptide, which contains 12 monomers of PEG, was optimal for siRNA delivery and also demonstrated a low risk of inflammatory response and toxicity in vivo following pulmonary administration.


Assuntos
Portadores de Fármacos/química , Pulmão/metabolismo , Peptídeos/química , RNA Interferente Pequeno/administração & dosagem , Doenças Respiratórias/terapia , Células A549 , Inativação Gênica , Humanos , Interações Hidrofóbicas e Hidrofílicas , Polietilenoglicóis/química , RNA Interferente Pequeno/genética , Doenças Respiratórias/genética , Solubilidade , Transfecção/métodos
12.
Viruses ; 13(3)2021 02 24.
Artigo em Inglês | MEDLINE | ID: mdl-33668216

RESUMO

Equine herpesvirus-1 is the cause of respiratory disease, abortion, and equine herpesvirus myeloencephalopathy (EHM) in horses worldwide. EHM affects as many as 14% of infected horses and a cell-associated viremia is thought to be central for EHM pathogenesis. While EHM is infrequent in younger horses, up to 70% of aged horses develop EHM. The aging immune system likely contributes to EHM pathogenesis; however, little is known about the host factors associated with clinical EHM. Here, we used the "old mare model" to induce EHM following EHV-1 infection. Peripheral blood mononuclear cells (PBMCs) of horses prior to infection and during viremia were collected and RNA sequencing with differential gene expression was used to compare the transcriptome of horses that did (EHM group) and did not (non-EHM group) develop clinical EHM. Interestingly, horses exhibiting EHM did not show respiratory disease, while non-EHM horses showed significant respiratory disease starting on day 2 post infection. Multiple immune pathways differed in EHM horses in response to EHV-1. These included an upregulation of IL-6 gene expression, a dysregulation of T-cell activation through AP-1 and responses skewed towards a T-helper 2 phenotype. Further, a dysregulation of coagulation and an upregulation of elements in the progesterone response were observed in EHM horses.


Assuntos
Infecções por Herpesviridae/virologia , Herpesvirus Equídeo 1/imunologia , Doenças dos Cavalos/imunologia , Doenças dos Cavalos/virologia , Leucócitos Mononucleares/virologia , Transcriptoma/genética , Animais , Feminino , Expressão Gênica/genética , Expressão Gênica/imunologia , Perfilação da Expressão Gênica/métodos , Infecções por Herpesviridae/imunologia , Cavalos , Interleucina-6/genética , Interleucina-6/imunologia , Leucócitos Mononucleares/imunologia , Ativação Linfocitária/genética , Ativação Linfocitária/imunologia , Masculino , Doenças Respiratórias/genética , Doenças Respiratórias/imunologia , Doenças Respiratórias/virologia , Linfócitos T/imunologia , Linfócitos T/virologia , Linfócitos T Auxiliares-Indutores/imunologia , Linfócitos T Auxiliares-Indutores/virologia , Transcriptoma/imunologia , Regulação para Cima/genética , Regulação para Cima/imunologia
13.
Mol Biol Rep ; 48(3): 2703-2711, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-33625688

RESUMO

Aspirin-exacerbated respiratory disease (AERD) is characterized by immune cells dysfunction. This study aimed to investigate the molecular mechanisms involved in AERD pathogenesis. Relevant literatures were identified by a PubMed search (2005-2019) of english language papers using the terms "Aspirin-exacerbated respiratory disease", "Allergic inflammation", "molecular mechanism" and "mutation". According to the significant role of inflammation in AERD development, ILC-2 is known as the most important cell in disease progression. ILC-2 produces cytokines that induce allergic reactions and also cause lipid mediators production, which activates mast cells and basophils, ultimately. Finally, Monoclonal antibody and Aspirin desensitization in patients can be a useful treatment strategy for prevention and treatment.


Assuntos
Aspirina/efeitos adversos , Progressão da Doença , Doenças Respiratórias/induzido quimicamente , Doenças Respiratórias/diagnóstico , Animais , Predisposição Genética para Doença , Humanos , Polimorfismo Genético , Prognóstico , Doenças Respiratórias/genética , Doenças Respiratórias/fisiopatologia
14.
Artigo em Inglês | MEDLINE | ID: mdl-32359341

RESUMO

OBJECTIVE: Asthma is an inflammatory airway disease affecting most of the population in the world. The current medication for asthma relieves airway inflammation but it has serious adverse effects. Biochanin A (BCA), a phytoestrogen, is an active component present in red clover, alfalfa, soy having anti-oxidant and anti-inflammatory properties. BCA was identified as a natural activator of peroxisome proliferator-activated receptor-gamma (PPARγ). METHODS: The study aims to evaluate the effects of BCA in ovalbumin (OVA)-induced murine model of asthma and to study the role of PPARγ. RESULTS: We found that BCA administration reduced the severity of murine allergic asthma as evidenced histologically, and measurement of allergen-specific IgE levels in serum as well as in BAL fluid. BCA also reversed the elevated levels of inflammatory cytokines, cell infiltration, protein leakage into the airways and expression of hemoxygenase-1 in OVA-induced lungs. Further, we confirmed that BCA mediated inhibitory effects are mediated through PPARγ as assessed by treatment with PPARγ antagonist GW9662. CONCLUSION: Our results suggest that BCA is efficacious in a preclinical model of asthma and may have the potential for the treatment of asthma in humans.


Assuntos
Genisteína/uso terapêutico , Inflamação/tratamento farmacológico , Doenças Respiratórias/tratamento farmacológico , Animais , Anti-Inflamatórios/uso terapêutico , Asma/induzido quimicamente , Asma/tratamento farmacológico , Asma/genética , Asma/patologia , Modelos Animais de Doenças , Feminino , Inflamação/induzido quimicamente , Inflamação/genética , Inflamação/patologia , Camundongos , Ovalbumina , PPAR gama/genética , PPAR gama/metabolismo , Doenças Respiratórias/induzido quimicamente , Doenças Respiratórias/genética , Doenças Respiratórias/patologia , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/genética , Resultado do Tratamento
16.
Genomics ; 112(6): 3968-3977, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-32650099

RESUMO

Bovine respiratory disease (BRD) is the most common disease in beef cattle and leads to considerable economic losses in both beef and dairy cattle. It is important to uncover the molecular mechanisms underlying BRD and to identify biomarkers for early identification of BRD cattle in order to address its impact on production and welfare. In this study, a longitudinal transcriptomic analysis was conducted using blood samples collected from 24 beef cattle at three production stages in the feedlot: 1) arrival (Entry group); 2) when identified as sick (diagnosed as BRD) and separated for treatment (Pulled); 3) prior to marketing (Close-out, representing healthy animals). Expressed genes were significantly different in the same animal among Entry, Pulled and Close-out stages (false discovery rate (FDR) < 0.01 & |Fold Change| > 2). Beef steers at both Entry and Pulled stages presented obvious difference in GO terms (FDR < 0.05) and affected biological functions (FDR < 0.05 & |Z-score| > 2) when compared with animals at Close-out. However, no significant functional difference was observed between Entry and Pulled animals. The interferon signaling pathway showed the most significant difference between animals at Entry/Pulled and Close-out stages (P < .001 & |Z-score| > 2), suggesting the animals initiated antiviral responses at an early stage of infection. Six key genes including IFI6, IFIT3, ISG15, MX1, and OAS2 were identified as biomarkers to predict and recognize sick cattle at Entry. A gene module with 169 co-expressed genes obtained from WGCNA analysis was most positively correlated (R = 0.59, P = 6E-08) with sickness, which was regulated by 11 transcription factors. Our findings provide an initial understanding of the BRD infection process in the field and suggests a subset of novel marker genes for identifying BRD in cattle at an early stage of infection.


Assuntos
Doenças dos Bovinos/genética , Bovinos/genética , Perfilação da Expressão Gênica , Doenças Respiratórias/veterinária , Animais , Estudos Longitudinais , Doenças Respiratórias/genética
17.
Pediatr Pulmonol ; 55(9): 2389-2401, 2020 09.
Artigo em Inglês | MEDLINE | ID: mdl-32662942

RESUMO

Founder mutations and autosomal recessive (AR) disorders are common in the Arabian Peninsula due to frequent consanguineous marriages. As a result, the pulmonary service at Tawam Hospital (Al Ain, UAE) routinely requests genetic testing for children with persistent (unexplained) respiratory problems. The main purpose of this report was to underscore the usefulness of these tests. Ten children with severe respiratory diseases due to complex genetic findings are described here. Forty-one variants (six novel) were detected, averaging four per patient (range: 1-9). Seven (17%) variants were homozygous and 34 (83%) heterozygous; some variants were known to show monoallelic expression. Using binomial probability distribution, the fetal-risk for having AR disorder(s) as a function of the number of shared variants by a couple ranged from 0.25 (having one shared variant) to 0.9249 (having nine shared variants). In cultures where increased size of homozygous genomic segments is common, children often have multiple variants that could cause complex clinical phenotypes. Identifying pathogenic variants assists in clinical care, family counseling, and disease prevention through genetic screening.


Assuntos
Doenças Respiratórias/genética , Criança , Pré-Escolar , Feminino , Testes Genéticos , Heterozigoto , Homozigoto , Humanos , Lactente , Masculino , Emirados Árabes Unidos
18.
Pharmacol Res ; 160: 105045, 2020 10.
Artigo em Inglês | MEDLINE | ID: mdl-32590100

RESUMO

MicroRNAs (miRNAs) are short single-stranded RNAs that have pivotal roles in disease pathophysiology through transcriptional and translational modulation of important genes. It has been implicated in the development of many diseases, such as stroke, cardiovascular conditions, cancers and inflammatory airway diseases. There is recent evidence that miRNAs play important roles in the pathogenesis of asthma and chronic obstructive pulmonary disease (COPD), and could help to distinguish between T2-low (non-eosinophilic, steroid-insensitive) versus T2-high (eosinophilic, steroid-sensitive) disease endotypes. As these are the two most prevalent chronic respiratory diseases globally, with rising disease burden, miRNA research might lead to the development of new diagnostic and therapeutic targets. Research involving miRNAs in airway disease is challenging because: (i) asthma and COPD are heterogeneous inflammatory airway diseases; there are overlapping but distinct inter- and intra-disease differences in the immunological pathophysiology, (ii) there exists more than 2000 known miRNAs and a single miRNA can regulate multiple targets, (iii) differential effects of miRNAs could be present in different cellular subtypes and tissues, and (iv) dysregulated miRNA expression might be a direct consequence of an indirect effect of airway disease onset or progression. As miRNAs are actively secreted in fluids and remain relatively stable, they have the potential for biomarker development and therapeutic targets. In this review, we summarize the preclinical data on potential miRNA biomarkers that mediate different pathophysiological mechanisms in airway disease. We discuss the framework for biomarker development using miRNA and highlight the need for careful patient characterization and endotyping in the screening and validation cohorts, profiling both airway and blood samples to determine the biological fluids of choice in different disease states or severity, and adopting an untargeted approach. Collaboration between the various stakeholders - pharmaceutical companies, laboratory professionals and clinician-scientists is crucial to reduce the difficulties and cost required to bring miRNA research into the translational stage for airway diseases.


Assuntos
MicroRNAs/fisiologia , Biossíntese de Proteínas , Doenças Respiratórias/genética , Doenças Respiratórias/fisiopatologia , Remodelação das Vias Aéreas/genética , Animais , Asma/genética , Asma/fisiopatologia , Marcadores Genéticos , Humanos , Inflamação/genética , Inflamação/fisiopatologia , MicroRNAs/análise , Doença Pulmonar Obstrutiva Crônica/genética , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Doenças Respiratórias/diagnóstico
19.
Vet Clin North Am Equine Pract ; 36(2): 243-253, 2020 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-32534858

RESUMO

Genetic factors influence the development of guttural pouch tympany, recurrent laryngeal neuropathy, severe equine asthma, exercise-induced pulmonary hemorrhage, and possibly also some malformations and infectious diseases of the respiratory tract. The current data suggest that most of these diseases are complex, resulting from the interaction between several genes and environmental factors. To date, no specific genes or causative mutations have been identified that would allow the development of practical genetic tests. In the future, genetic profiling panels, based on multiple genetic markers and environmental risk factors, may allow identification of individuals with an increased genetic risk.


Assuntos
Doenças dos Cavalos/genética , Doenças Respiratórias/veterinária , Animais , Cavalos , Doenças Respiratórias/genética
20.
Biomolecules ; 10(1)2020 01 07.
Artigo em Inglês | MEDLINE | ID: mdl-31936183

RESUMO

Non-steroidal anti-inflammatory drugs (NSAID) exacerbated respiratory disease (N-ERD) is a disease integrated by asthma, nasal polyps, and hypersensitivity to non-steroidal anti-inflammatory drugs (NSAID). Genetic association studies have explored single nucleotide polymorphisms (SNPs) in genes involved in theoretical pathophysiological mechanisms, but most of these lack replication of findings in second populations. Our objective was to evaluate the association of SNPs in candidate genomic regions described in Asian and European subjects with N-ERD in Mexican-mestizo patients. We designed a replicative study in two stages. We included 381 SNPs selected by fine mapping of associated genes in a microarray, which were tested in three groups: N-ERD (N), asthma (A), and control group (CG); by means of GoldenGate array, positive results by genetic models were validated in the second stage in another population through qPCR with the same methodology. In the allelic model, we identified 11 SNPs in N vs. CG comparison, and five in N vs. A and A vs. CG, respectively. By genetics models, all SNPs in PPARG, rs13239058 in TBXAS1, and rs1554286 and rs1800872 in IL10 were associated in both models. In the second stage, only rs1800872CC showed an association in the dominant model comparing N vs. GC, p = 0.004, OR = 0.44. In conclusion, rs1800872 in IL10 was the only associated with N-ERD in Mexican-mestizo patients.


Assuntos
Interleucina-10/genética , Doenças Respiratórias/tratamento farmacológico , Doenças Respiratórias/genética , Adulto , Alelos , Anti-Inflamatórios não Esteroides/farmacologia , Asma/tratamento farmacológico , Asma/fisiopatologia , Estudos de Casos e Controles , Feminino , Frequência do Gene/genética , Estudos de Associação Genética , Predisposição Genética para Doença/genética , Genótipo , Humanos , Interleucina-10/metabolismo , Masculino , México/epidemiologia , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único/genética , Síndrome do Desconforto Respiratório/tratamento farmacológico , Síndrome do Desconforto Respiratório/genética , Doenças Respiratórias/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...